Significant Ownership of BIOGEN INC.
- Signature - Title
- /s/ Wendell Taylor - Wendell Taylor / Secretary
- Location
- Cambridge, MA
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by BIOGEN INC..
Follow Filing Activity
Follow BIOGEN INC. and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of BIOGEN INC.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| APLS | APELLIS PHARMACEUTICALS, INC. | Common Stock, par value $0.0001 per share | 14% | $339,653,645 | 18,469,475 | BIOGEN INC. | 31 Mar 2026 | ||
| SAGE | Sage Therapeutics, Inc. | Common Stock, par value $0.0001 per share | 0% | $0 | -$56,922,234 | 0 | -100% | Biogen Inc. | 30 Jul 2025 |
Schedules 13D/G Reported by BIOGEN INC.:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.